var nfm_array=new Array(
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276248186','Ligand%20%3Cstrong%3EPharmaceuticals%3C%2Fstrong%3E%20Incorporated%20Q4%202009%20Earnings%20Call%20Transcript','9%20Feb%202010%2019%3A56','...%20Speaking%20for%20Ligand%20%3Cstrong%3EPharmaceuticals%3C%2Fstrong%3E%20will%20be%20Mr%20John%20Higgins%2C%20President%20and%20%20...%20%20very%20strong%20year%20financially.%20We%20are%20a%20%3Cstrong%3Ebiotech%3C%2Fstrong%3E%20company%2C%20many%20of%20our%20peers%20do%20not%20%20...%20%20enrolled.%20Also%20GSK%20filed%20an%20NDA%20in%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20for%20ITP%2C%20I%20will%20have%20another%20slide%20%20...','Seeking%20Alpha'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276230818','Reportlinker%20Adds%20Chronic%20Obstructive%20Pulmonary%20Disease%20%28COPD%29%20-%20%3Cstrong%3EDrug%3C%2Fstrong%3E%20Pipeline%20Analysis%20and%20Market%20Forecasts%20to%202016','9%20Feb%202010%2018%3A33','...%20%20Adds%20Chronic%20Obstructive%20Pulmonary%20Disease%20%28COPD%29%20-%20%3Cstrong%3EDrug%3C%2Fstrong%3E%20Pipeline%20Analysis%20and%20Market%20Forecasts%20to%202016%20%20...%20%20COPD%20market%2C%20a%20key%20segment%20within%20the%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20and%20healthcare%20industry.%20This%20%3Cstrong%3Epharma%3C%2Fstrong%3E%20report%20identifies%20%20...%20%20%28United%20Kingdom%29%2C%20Italy%2C%20Spain%2C%20Germany%2C%20France%20and%20%3Cstrong%3EJapan.%3C%2Fstrong%3E%20-%20Pipeline%20analysis%20data%20providing%20a%20split%20%20...','IT%20News%20Online'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276110129','Pfizer%27s%20novel%20NGF%20pain%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20is%20potential%20game%20changer','9%20Feb%202010%2005%3A36','...%20Pfizer%27s%20novel%20NGF%20pain%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20is%20potential%20game%20changer%20Feb%2008%2C%202010%20%20...%20%20across%20the%20seven%20major%20markets%20%28the%20US%2C%20%3Cstrong%3EJapan%2C%3C%2Fstrong%3E%20France%2C%20Germany%2C%20Italy%2C%20Spain%20and%20the%20UK%29.%20%20...%20%20to%20represent%20an%20attractive%20commercial%20opportunity%20for%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20developers.%20Tanezumab%20is%20a%20humanized%20monoclonal%20antibody%20%20...','Therapeutics%20Daily'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276162094','Research%20and%20Markets%3A%20Breast%20Cancer%20-%20%3Cstrong%3EDrug%3C%2Fstrong%3E%20Pipeline%20Analysis%20and%20Market%20Forecasts%20to%202016','9%20Feb%202010%2012%3A24','...%20%20the%20current%20competitive%20landscape%20for%20breast%20cancer%20%3Cstrong%3Edrugs%3C%2Fstrong%3E%20and%20found%20the%20competition%20to%20be%20strong.%20%20...%20%20%28United%20Kingdom%29%2C%20Italy%2C%20Spain%2C%20Germany%2C%20France%2C%20and%20%3Cstrong%3EJapan.%3C%2Fstrong%3E%20Pipeline%20analysis%20data%20providing%20a%20split%20across%20%20...%20%20USA%20Inc%2C%20Apthera%20Inc%2C%20Novartis%20AG%2C%20OncoGenex%20%3Cstrong%3EPharmaceuticals%2C%3C%2Fstrong%3E%20Amgen%2C%20Johnson%20%26amp%3B%20Johnson%2C%20Schering-Plough%20and%20AstraZeneca.%20%20...','TMCNet'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276136556','3SBio%20Gains%20China%20Rights%20to%20Another%20Dialysis%20%3Cstrong%3EDrug%3C%2Fstrong%3E','9%20Feb%202010%2009%3A34','...%20%20all%20costs%20of%20gaining%20approval%20of%20the%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20in%20China.%20It%20will%20also%20pay%20royalties%20%20...%20%20begun%20Phase%20III%20trials%20in%20the%20US%2C%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20and%20Taiwan.%20Last%20month%2C%203SBio%20announced%20it%20%20...%20%20China%20rights%20for%20the%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20from%20AMAG%20%3Cstrong%3EPharmaceuticals%3C%2Fstrong%3E%20%28NSDQ%3A%20%29%20in%20May%202009.%20According%20to%20%20...','Seeking%20Alpha'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276155847','Novartis%20buys%20rights%20to%20Debiopharm%27s%20hep%20C%20%3Cstrong%3Edrug%3C%2Fstrong%3E','9%20Feb%202010%2011%3A48','...%20Novartis%20buys%20rights%20to%20Debiopharm%27s%20hep%20C%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20Novartis%20has%20gained%20exclusive%20rights%20to%20develop%20%20...%20%20and%20marketing%20rights%20to%20the%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20%28excluding%20Japan%29%2C%20which%20is%20currently%20in%20Phase%20IIb%20trials.%20%20...%20%20Epstein%2C%20the%20new%20chief%20executive%20of%20Novartis%20%3Cstrong%3EPharma%2C%3C%2Fstrong%3E%20said%20that%20hepatitis%20C%20is%20sometimes%20referred%20%20...','PharmaTimes'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276170705','Novartis%20gain%20rights%20to%20hepatitis%20C%20%3Cstrong%3Edrug%3C%2Fstrong%3E','9%20Feb%202010%2013%3A17','...%20Novartis%20gain%20rights%20to%20hepatitis%20C%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20Novartis%20has%20gained%20the%20exclusive%20rights%20to%20%20...%20%20upfront%20payment%20to%20Debiopharm%20Group%2C%20an%20independent%20biopharmaceuticals%20company%20based%20in%20Switzerland%2C%20with%20Novartis%20receiving%20%20...%20%20exclusive%20worldwide%20development%20and%20marketing%20rights%20%28excluding%20Japan%29.%20Debiopharm%20will%20also%20be%20eligible%20for%20milestone%20%20...','Pharmaceutical%20Marketing'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276179489','Daiichi%20%3Cstrong%3ESankyo%3C%2Fstrong%3E%20files%20Japanese%20new%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20application%20for%20Alzheimer%27s%20%3Cstrong%3Edrug%3C%2Fstrong%3E','9%20Feb%202010%2014%3A11','...%20Daiichi%20%3Cstrong%3ESankyo%3C%2Fstrong%3E%20files%20Japanese%20new%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20application%20for%20Alzheimer%27s%20%20...%20%20Company%20has%20reported%20that%20its%20subsidiary%2C%20Asubio%20%3Cstrong%3EPharma%2C%3C%2Fstrong%3E%20has%20submitted%20a%20new%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20application%20in%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20for%20the%20manufacturing%20and%20marketing%20of%20SUN%20%20...','Quote.com'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276164254','Daiichi%20%3Cstrong%3ESankyo%3C%2Fstrong%3E%20subsidiary%20submits%20NDA%20for%20SUN%20Y7017%20in%20%3Cstrong%3EJapan%3C%2Fstrong%3E','9%20Feb%202010%2012%3A48','...%20Daiichi%20%3Cstrong%3ESankyo%3C%2Fstrong%3E%20has%20announced%20that%20its%20subsidiary%2C%20Asubio%20%3Cstrong%3EPharma%2C%3C%2Fstrong%3E%20has%20submitted%20a%20New%20%3Cstrong%3EDrug%3C%2Fstrong%3E%20Application%20in%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20for%20the%20manufacturing%20and%20marketing%20of%20SUN%20Y7017%20%28%3Cstrong%3Egeneric%3C%2Fstrong%3E%20name%3A%20Memantine%20hydrocholoride%29%20It%20was%20%20...','New%20Statesman'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276219627','PPD%20Reports%20Fourth%20Quarter%20and%20Full%20Year%202009%20Financial%20Results','9%20Feb%202010%2017%3A32','...%20%20net%20revenue%20included%20two%20milestone%20payments%20from%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Company%20Limited%20totaling%20%2418.0%20million%20triggered%20by%20%20...%20%20of%20its%20NDA%20for%20alogliptin%20to%20the%20%3Cstrong%3EMinistry%20of%20Health%2C%3C%2Fstrong%3E%20Labour%20and%20Welfare%20in%20%3Cstrong%3EJapan.%3C%2Fstrong%3E%20Discovery%20sciences%20segment%20loss%20from%20operations%20for%20%20...','Pharmalive.com%2F'],['http%3A%2F%2Fwww.einnews.info%2Fnews_publication.php%3F','Want%20more%20news%20on%20this%20topic%20delivered%20to%20you%20daily%20for%20free%3F%20Click%20here%20%26raquo%3B','','',''],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276182700','Takeda%20Announces%20Initiation%20of%20Trial%20to%20Study%20the%20Concomitant%20Use%20of%20Dexlansoprazole%20and%20Other%20Proton%20Pump%20Inhibitors%20With%20Plavix%28R%29%20%28Clopidogrel%20Bisulfate%29','9%20Feb%202010%2014%3A20','...%20%20Please%20visit%20the%20KAPIDEX%20Web%20site%20at%20%3Cstrong%3ETakeda%20Pharmaceuticals%3C%2Fstrong%3E%20North%20America%2C%20Inc.%20and%20Takeda%20Global%20Research%20%20...%20%20%26amp%3B%20Development%20Center%2C%20Inc.%20are%20subsidiaries%20of%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Company%20Limited%2C%20the%20largest%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20company%20in%20%3Cstrong%3EJapan.%3C%2Fstrong%3E%20The%20respective%20companies%20currently%20market%20oral%20diabetes%2C%20%20...','Market%20Wire'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276184069','Takeda%20Announces%20Initiation%20of%20Trial%20to%20Study%20the%20Concomitant%20Use%20of%20Dexlansoprazole%20and%20Other%20Proton%20Pump%20Inhibitors%20wi','9%20Feb%202010%2014%3A32','...%20%20Development%20Center%2C%20Inc%20Based%20in%20Deerfield%2C%20Ill.%2C%20%3Cstrong%3ETakeda%20Pharmaceuticals%3C%2Fstrong%3E%20North%20America%2C%20Inc.%20and%20Takeda%20Global%20Research%20%20...%20%20%26amp%3B%20Development%20Center%2C%20Inc.%20are%20subsidiaries%20of%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Company%20Limited%2C%20the%20largest%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20company%20in%20%3Cstrong%3EJapan.%3C%2Fstrong%3E%20The%20respective%20companies%20currently%20market%20oral%20diabetes%2C%20%20...','News%20Blaze'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276138843','Japanese%20Market%20Ends%20Lower%3B%20Buying%20On%20Dips%20Limits%20Losses','9%20Feb%202010%2009%3A50','...%20%20%2471.89%20a%20barrel%20in%20New%20York%20on%20Monday.%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20stocks%20ended%20in%20negative%20territory.%20%3Cstrong%3ETakeda%20Pharmaceuticals%3C%2Fstrong%3E%20fell%202.62%25%2C%20%3Cstrong%3EEisai%3C%2Fstrong%3E%20Co.%20lost%201.35%25%2C%20%3Cstrong%3EChugai%3C%2Fstrong%3E%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20Company%20shed%202.52%25%2C%20%3Cstrong%3EAstellas%3C%2Fstrong%3E%20%3Cstrong%3EPharma%3C%2Fstrong%3E%20slipped%201.21%25%20and%20Dainippon%20Sumitomo%20%3Cstrong%3EPharma%3C%2Fstrong%3E%20declined%202.63%25.%20Among%20land%20transport%20stocks%2C%20Yamato%20%20...','Quote.com'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276173280','Asian%20Markets%20End%20In%20Positive%20Territory%20On%20Bargain%20Hunting','9%20Feb%202010%2013%3A34','...%20%20the%20previous%20year%2C%20while%20domestic%20orders%20climbed%2078.9%25.%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20stocks%20ended%20in%20negative%20territory.%20%3Cstrong%3ETakeda%20Pharmaceuticals%3C%2Fstrong%3E%20fell%202.62%25%2C%20%3Cstrong%3EEisai%3C%2Fstrong%3E%20Co.%20lost%201.35%25%2C%20%3Cstrong%3EChugai%3C%2Fstrong%3E%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20Company%20shed%202.52%25%2C%20%3Cstrong%3EAstellas%3C%2Fstrong%3E%20%3Cstrong%3EPharma%3C%2Fstrong%3E%20slipped%201.21%25%20and%20Dainippon%20Sumitomo%20%3Cstrong%3EPharma%3C%2Fstrong%3E%20declined%202.63%25.%20Among%20land%20transport%20stocks%2C%20Yamato%20%20...','Quote.com'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276110339','%3Cstrong%3EJapan%3C%2Fstrong%3E%20Hot%20Stocks-Defensive%20stocks%2C%20J%3ACom%2C%20Asahi%2C%20Koito%2C%20Toshiba','9%20Feb%202010%2005%3A37','...%20%20up%20some%20that%20have%20fallen%20sharply%20recently.%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Co%20slid%202.5%20percent%20to%203%2C900%20yen%20and%20%3Cstrong%3EChugai%3C%2Fstrong%3E%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20Co%20fell%202.5%20percent%20to%201%2C742%20%20...%20%20declined%202.1%20percent%20to%202%2C190%20yen%2C%20while%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20Tobacco%20Inc%20shed%202.3%20percent%20to%20312%2C500%20%20...','FinanzNachrichten'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276153510','Nikkei%20falls%20to%202-month%20closing%20low%2C%20but%20Toyota%20gains','9%20Feb%202010%2011%3A20','...%20%3Cstrong%3ETOKYO%3C%2Fstrong%3E%20-%20%3Cstrong%3EJapan%3C%2Fstrong%3E%27s%20Nikkei%20stock%20average%20edged%20down%20to%20a%20%20...%20%20so-called%20defensive%20stocks%20such%20as%20drugmakers%20fell.%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Co%20slid%202.6%20per%20cent%20to%203%2C895%20and%20%3Cstrong%3EChugai%3C%2Fstrong%3E%20%3Cstrong%3EPharmaceutical%3C%2Fstrong%3E%20Co%20fell%202.5%20per%20cent%20to%20%20...','Business%20Spectator'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276163228','XOMA%20Initiates%20Phase%202b%20Dose-Ranging%20Clinical%20Trial%20of%20XOMA%20052%20in%20Type%202%20Diabetes%20Patients','9%20Feb%202010%2012%3A44','...%20%20as%20through%20license%20and%20collaborative%20agreements%20with%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20and%20%3Cstrong%3Ebiotechnology%3C%2Fstrong%3E%20companies%2C%20and%20under%20its%20contracts%20with%20the%20%20...%20%20Novartis%20AG%2C%20Merck%20%26amp%3B%20Co.%2C%20Inc.%20and%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Company%20Limited.%20XOMA%27s%20technologies%20have%20contributed%20to%20%20...','Stockwatch'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276179252','Tekmira%20%3Cstrong%3EPharmaceuticals%3C%2Fstrong%3E%20Announces%202010%20Milestones','9%20Feb%202010%2014%3A11','...%20%20--%20%28MARKET%20WIRE%29%20--%2002%2F09%2F10%20--%20Tekmira%20%3Cstrong%3EPharmaceuticals%3C%2Fstrong%3E%20Corporation%20%28TSX%3A%20%29%2C%20a%20leading%20developer%20of%20%20...%20%20cholesterol.%20-%20Filing%20of%20an%20investigational%20new%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20%28IND%29%20application%20and%20initiation%20of%20a%20Phase%20%20...%20%20expects%20other%20collaborators%2C%20including%20Bristol-Myers%20Squibb%20and%20%3Cstrong%3ETakeda%20Pharmaceutical%3C%2Fstrong%3E%20Company%20Limited%2C%20to%20continue%20to%20employ%20SNALP%20%20...','Street%20Insider'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276156191','Orion%20group%20financial%20statement%20release%20of%202009','9%20Feb%202010%2011%3A49','...%20%20of%20products%20already%20on%20the%20market%20%28mainly%20%3Cstrong%3Egeneric%3C%2Fstrong%3E%20products%29%20are%20now%20recognised%20in%20cost%20of%20%20...%20%20further%20intensified%20price%20competition%2C%20so%20the%20domestic%20%3Cstrong%3Epharmaceutical%3C%2Fstrong%3E%20market%20did%20not%20grow%20during%20the%20period%20%20...%20%2024%20hours.%20In%20the%20United%20States%20and%20%3Cstrong%3EJapan%2C%3C%2Fstrong%3E%20for%20example%2C%20the%20%3Cstrong%3Edrug%3C%2Fstrong%3E%20is%20already%20available%20%20...','Kauppalehti'],
['http%3A%2F%2Fwww.einnews.com%2Fnfm_news.php%3Fwid%3D276119869','Lupin%20Receives%20FDA%20Approval%20For%20Amlodipine%2FBenazepril%20Capsules','9%20Feb%202010%2006%3A52','...%20%20For%20Amlodipine%2FBenazepril%20Capsules%20Baltimore%2CMD%20%2FPRNewswire%2F%20--%20Lupin%20%3Cstrong%3EPharmaceuticals%2C%3C%2Fstrong%3E%20Inc.%20announced%20recently%20that%20the%20U.S.%20Food%20%20...%20%20commenced.%20Lupin%27s%20Amlodipine%2FBenazepril%20capsules%20are%20the%20AB-rated%20%3Cstrong%3Egeneric%3C%2Fstrong%3E%20equivalent%20of%20Novartis%27%20Lotrel%26reg%3B%20capsules%20indicated%20for%20%20...%20%20prescriptions%20%26amp%3B%20growing%20at%2092%20%25%29%20and%20%3Cstrong%3EJapan%3C%2Fstrong%3E%20%28ranked%207th%20and%20growing%20at%2023%25%29.%20The%20%20...','Pharmaceutical%20Online']
)
if(typeof(nfm_array)!='undefined') nfm_articles(nfm_array);
if((typeof(nfm_array)=='undefined')||(!nfm_array.length)) {
nfm_articles_error('We are sorry, no news on today. Please come back later or browse hundreds of related newsletters at EIN News.');
}
nfm_array=void 0;
document.writeln('');
function nfm_verify()
{
var a=document.getElementById('nfmaker_anchor');
if(a) {
var e=a.nextSibling;
while(e&&(e.nodeType==3)) e=e.nextSibling;
if(!e) {
m=document.createElement('a');
m.href="http://www.einnews.com/search.php?makesearch=yes&keywords=%22takeda+pharmaceuticals%22+OR+%22takeda+pharmaceutical%22+OR+sankyo+OR+astellas+OR+eisai+OR+chugai+OR+shionogi+OR+%22otsuka+pharmaceutical%22+OR+%28+%28+japan+OR+tokyo%29+AND+%28+%28+%22ministry+of+health%22+OR+%22health+ministry%22+%29+OR+pharma%2A+OR+biotech%2A+OR++%E2%80%9Cgeneric+drug%E2%80%9D+OR+%E2%80%9Cgeneric+drugs%E2%80%9D+OR+%22generics+of%22+%29+%29";
a.appendChild(m);
a.style.display='block';
var t=document.createTextNode('more ...');
m.appendChild(t);
} else {
if(e.nodeName!='DIV') return;
var is_ok=0;
for(var g=e.firstChild;g;g=g.nextSibling) {
if(g.nodeType==3) {
if(g.data.match(/Powered/i)) is_ok|=2;
}
if((g.nodeType!=3)&&(g.nodeName=='A')) {
is_ok|=1;
if(!g.firstChild) {
var t=document.createTextNode('more ...');
g.appendChild(t);
}
}
}
if(!(is_ok&1)) {
m=document.createElement('a');
m.href="http://www.einnews.com/search.php?makesearch=yes&keywords=%22takeda+pharmaceuticals%22+OR+%22takeda+pharmaceutical%22+OR+sankyo+OR+astellas+OR+eisai+OR+chugai+OR+shionogi+OR+%22otsuka+pharmaceutical%22+OR+%28+%28+japan+OR+tokyo%29+AND+%28+%28+%22ministry+of+health%22+OR+%22health+ministry%22+%29+OR+pharma%2A+OR+biotech%2A+OR++%E2%80%9Cgeneric+drug%E2%80%9D+OR+%E2%80%9Cgeneric+drugs%E2%80%9D+OR+%22generics+of%22+%29+%29";
e.appendChild(m);
var t=document.createTextNode('more ...');
m.appendChild(t);
}
if(!(is_ok&2)) {
m=document.createElement('br');
e.appendChild(m);
var t=document.createTextNode('Powered by ');
e.appendChild(t);
m=document.createElement('a');
m.href='http://www.newsfeedmaker.com/';
var t=document.createTextNode('Newsfeed Maker');
m.appendChild(t);
e.appendChild(m);
}
}
}
}
setTimeout('nfm_verify()',10);